Australia's Orthocell jumps after nerve repair product sale

Orthocell

10/12/2025 02:33

** Shares of Australia's Orthocell OCC.AX rise 6.9% to A$1.085, set for best day since September 30 if current gains hold

** Stock at its highest level since December 1

** Regenerative medicine co announces its first commercial sale of Remplir, its nerve repair product, in Hong Kong

** Shares down 19.9% YTD

 (Reporting by Shruti Agarwal in Bengaluru)

 ((Shruti.Agarwal@thomsonreuters.com))